© 2023 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#COVID-19 treatment

Two scientists cooperating while examining antiviral drug in a test tube at laboratory
FDA Approves Remdesivir for Hospitalized COVID-19 Patients
coronavirus
NIH Study Aims To Identify Promising COVID-19 Treatments for Larger Trials
Senior patient in hospital bed nurse
How is COVID-19 treated?
Generic image

COVID-19 Health Basics

These Basics offer need-to-know facts on a variety of COVID-19 topics.

Tenofovir and COVID: The Jury Is Still Out

Research on the links between tenofovir and other antiretrovirals, SARS-CoV-2 infection and COVID severity has produced mixed results.

Few Firm Beliefs and Low Trust: Americans Not Sure What’s True in Age of Health Misinformation

The confusion about what’s true—and who’s telling the truth—is of critical importance to public health.

Project NextGen Awards Over $1.4 Billion to Develop the Future of COVID-19 Vaccines and Therapeutics

Funding includes $1 billion for vaccine trials, $326 million for a new monoclonal antibody and $100 million for novel technologies.

People With HIV Remain at Greater Risk for Death Due to COVID-19

COVID mortality declined overall during the omicron wave but less so for people with HIV.

NIH Launches Long COVID Clinical Trials Through RECOVER Initiative

The first studies, launched on July 31, will focus on viral persistence and cognitive dysfunction.

White House Launches Office of Pandemic Preparedness and Response Policy

New office will take over the duties of the current White House COVID-19 and mpox response teams.
Novel coronavirus SARS-CoV-2

Designing a SARS-CoV-2 Decoy

A molecular decoy that neutralizes the SARS-CoV-2 virus by preventing it from latching onto cells protected mice against COVID-19.

Much Remains to Be Learned About Long COVID

Several mechanisms may play a role, including persistent virus and ongoing immune dysregulation.

Era of ‘Free’ COVID Vaccines, Test Kits, and Treatments Is Ending. Who Will Pay the Tab Now?

People without insurance will need to either pay full price, seek free or low-cost vaccines from community clinics or go without.

Evusheld Is No Longer Effective for COVID PrEP

Monoclonal antibodies used to prevent COVID-19 in immunocompromised people aren’t active against new virus variants.

What Older Americans Need to Know About Taking Paxlovid

Before they get COVID, people over 65 should have a plan for accessing antiviral treatment.

NIH Launches Home Test to Treat, a Pilot COVID-19 Telehealth Program

Berks County, Pennsylvania, is the first community to join a partnership with local public health departments.
Colorized scanning electron micrograph of a cell (blue) infected with the Omicron strain of SARS-CoV-2 virus particles (yellow)

Paxlovid Reduces Serious Risks from COVID Omicron Variants

The antiviral treatment reduced the risk of hospitalization or death from SARS-CoV-2 Omicron variants in older adults by 44%.

FDA Warns Evusheld May Not Protect Against Certain COVID-19 Variants

The monoclonal antibody combo is used as pre-exposure prophylaxis for immunocompromised people who may not respond to COVID-19 vaccines.

Detainees Dread COVID While Awaiting Immigration Hearings

At least 11 people have died from COVID-19 while in ICE custody, but advocates say that may be an underestimate.
Advertisement
Ask COVID Health
Features

COVID Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

COVID Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.